STK11 and adenocarcinoma: An experimental KRAS-mutated LKB1-deficient model has been established in mice, showing that LKB1-deficient adenocarcinoma progressively transdifferentiates into SCC via an intermediate pathologically mixed adenosquamous histotype [172].